NCT00352950View on ClinicalTrials.gov

Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2006

Study Completion Date

February 29, 2008

Conditions

OncologyNon-Small Cell Lung Cancer

Interventions

DRUG

AMG 954/Panitumumab

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT00352950 - Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter